• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶组织抑制剂-1、-2和-3在人隐静脉器官培养新生内膜形成过程中的表达

Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.

作者信息

Kranzhöfer A, Baker A H, George S J, Newby A C

机构信息

Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom.

出版信息

Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):255-65. doi: 10.1161/01.atv.19.2.255.

DOI:10.1161/01.atv.19.2.255
PMID:9974405
Abstract

Degradation of the extracellular basement membrane is implicated in atherosclerosis, restenosis after angioplasty, and intimal thickening of vein grafts. Upregulation of metalloproteinase (MMP)-2 and MMP-9 accompanies neointima formation in cholesterol-fed rabbits, in rat and pig models of angioplasty, and in organ cultures of human saphenous veins. MMPs are inhibited by binding to tissue inhibitors of MMPs (TIMPs). Relatively little is known about their regulation in relationship to neointima formation; thus, we investigated TIMP expression in the organ culture model. Qualitative reverse transcriptase-polymerase chain reaction of mRNA extracted from veins showed that TIMP-1, TIMP-2, and TIMP-3 are each expressed before and after culture. Zymography revealed that TIMP-1 was the most abundant TIMP secreted and that its secretion increased dramatically between 0 to 2 and 12 to 14 days of culture. An enzyme-linked immunosorbent assay showed that TIMP-1 secretion increased from 3.2+/-1.5 (mean+/-SE) to 32+/-6 ng/mg wet weight per day (n=5, P<0.01). Immunocytochemical testing localized the increased expression of TIMP-1 to neointimal smooth muscle cells. Although less abundant, TIMP-2 secretion also increased from 0.8+/-0. 3 to 4.7+/-0.2 ng/mg wet weight per day (n=5, P<0.001), and tissue levels increased from 33+/-7 to 150+/-70 ng/mg wet weight (P<0.05). TIMP-2 was also immunolocalized to neointimal smooth muscle cells and their surrounding matrix. TIMP-3 was not secreted but was detected variably and constitutively in tissue extracts (160+/-120 and 170+/-100 ng/mg wet weight [n=9] on days 2 and 14, respectively). TIMP-3 was found in the cells and extracellular matrix of the media and adventitia before culture and to a lesser extent in the neointima after 14 days of culture. Rates of total TIMP secretion on day 14 exceeded those of MMP-2 and MMP-9 (10.6+/-1.9 and 15.6+/-2.3 ng/mg wet weight per day, respectively). Consistent with this, in situ zymography showed that MMP gelatinase activity was highly localized to cell bodies in the media and neointima. Secretion of TIMP-1 and TIMP-2 is greatly increased during neointima formation in human saphenous veins. TIMP-1 is readily released, whereas TIMP-2 remains partially attached and TIMP-3 exclusively attached to the extracellular matrix. Regulation of TIMP expression is therefore an important determinant of net MMP activity during neointima formation, restricting it to the pericellular environment.

摘要

细胞外基底膜的降解与动脉粥样硬化、血管成形术后再狭窄以及静脉移植物内膜增厚有关。在喂食胆固醇的兔子、大鼠和猪的血管成形术模型以及人隐静脉的器官培养中,金属蛋白酶(MMP)-2和MMP-9的上调伴随着新生内膜的形成。MMP通过与MMP组织抑制剂(TIMP)结合而受到抑制。关于它们在与新生内膜形成相关的调节方面了解相对较少;因此,我们在器官培养模型中研究了TIMP的表达。从静脉中提取的mRNA的定性逆转录聚合酶链反应表明,TIMP-1、TIMP-2和TIMP-3在培养前后均有表达。酶谱分析显示,TIMP-1是分泌最多的TIMP,其分泌在培养的0至2天和12至14天之间显著增加。酶联免疫吸附测定表明,TIMP-1的分泌从3.2±1.5(平均值±标准误)增加到每天32±6 ng/mg湿重(n = 5,P<0.01)。免疫细胞化学检测将TIMP-1的表达增加定位到新生内膜平滑肌细胞。虽然含量较少,但TIMP-2的分泌也从每天0.8±0.3增加到4.7±0.2 ng/mg湿重(n = 5,P<0.001),组织水平从33±7增加到150±70 ng/mg湿重(P<0.05)。TIMP-2也免疫定位到新生内膜平滑肌细胞及其周围基质。TIMP-3不分泌,但在组织提取物中可检测到且组成性存在(培养第2天和第14天分别为160±120和170±100 ng/mg湿重[n = 9])。培养前在中膜和外膜的细胞及细胞外基质中发现TIMP-3,培养14天后在新生内膜中含量较少。第14天TIMP的总分泌率超过MMP-2和MMP-9(分别为每天10.6±1.9和15.6±2.3 ng/mg湿重)。与此一致,原位酶谱分析表明MMP明胶酶活性高度定位于中膜和新生内膜的细胞体。在人隐静脉新生内膜形成过程中,TIMP-1和TIMP-2的分泌大幅增加。TIMP-1易于释放,而TIMP-2仍部分附着,TIMP-3仅附着于细胞外基质。因此,TIMP表达的调节是新生内膜形成过程中MMP净活性的重要决定因素,将其限制在细胞周围环境。

相似文献

1
Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.金属蛋白酶组织抑制剂-1、-2和-3在人隐静脉器官培养新生内膜形成过程中的表达
Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):255-65. doi: 10.1161/01.atv.19.2.255.
2
Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein.腺病毒介导的人TIMP - 1基因转移抑制人隐静脉平滑肌细胞迁移和新生内膜形成。
Hum Gene Ther. 1998 Apr 10;9(6):867-77. doi: 10.1089/hum.1998.9.6-867.
3
Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.短期接触毒胡萝卜素可抑制人隐静脉新生内膜的形成。
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2500-6. doi: 10.1161/01.atv.17.11.2500.
4
Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.金属蛋白酶及其抑制剂在出生后发育中的大鼠小脑中的时空表达模式。
J Neurosci. 1999 Jun 15;19(12):4994-5004. doi: 10.1523/JNEUROSCI.19-12-04994.1999.
5
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.实验性胆汁性肝纤维化中基质金属蛋白酶及其抑制剂之间的平衡改变
Am J Pathol. 1998 Dec;153(6):1895-902. doi: 10.1016/S0002-9440(10)65703-3.
6
Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.靶向尿激酶型纤溶酶原激活物受体的基质金属蛋白酶抑制剂TIMP-1.ATF的基因转移比金属蛋白酶组织抑制剂-1更有效地抑制新生内膜形成。
Circ Res. 2002 Nov 15;91(10):945-52. doi: 10.1161/01.res.0000041418.51906.57.
7
Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.腺病毒介导的金属蛋白酶组织抑制剂-3过表达对人和猪模型中晚期静脉移植物新生内膜形成的抑制作用
Circulation. 2000 Jan 25;101(3):296-304. doi: 10.1161/01.cir.101.3.296.
8
Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.血流调节静脉移植物重塑过程中基质金属蛋白酶的差异表达与活性
J Vasc Surg. 2004 May;39(5):1084-90. doi: 10.1016/j.jvs.2003.12.031.
9
Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts.猪大隐静脉至颈动脉间置移植术中基底膜降解金属蛋白酶分泌增加。
Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1640-9. doi: 10.1161/01.atv.19.7.1640.
10
Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.金属蛋白酶组织抑制剂-2的基因转移可抑制人隐静脉中的金属蛋白酶活性和新生内膜形成。
Gene Ther. 1998 Nov;5(11):1552-60. doi: 10.1038/sj.gt.3300764.

引用本文的文献

1
Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.载病毒载体基因治疗内膜增生和动脉粥样硬化猪再狭窄。
Drug Deliv Transl Res. 2018 Aug;8(4):918-927. doi: 10.1007/s13346-017-0409-0.
2
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.基质金属蛋白酶-9与基质金属蛋白酶组织抑制剂-1的失衡可能导致小脑动静脉畸形出血。
Neural Regen Res. 2012 Jul 5;7(19):1513-9. doi: 10.3969/j.issn.1673-5374.2012.19.011.
3
The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model.
过氧化物酶体增殖物激活受体γ激动剂罗格列酮对兔颈动脉吻合模型中新生内膜增生的影响。
J Cardiothorac Surg. 2012 Jun 20;7:57. doi: 10.1186/1749-8090-7-57.
4
Matrix metalloproteinases and atherosclerosis.基质金属蛋白酶与动脉粥样硬化
Curr Atheroscler Rep. 2004 Mar;6(2):112-20. doi: 10.1007/s11883-004-0099-1.
5
Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.动脉粥样硬化人类血管中巨细胞病毒感染增强。
Am J Pathol. 2004 Feb;164(2):589-600. doi: 10.1016/S0002-9440(10)63148-3.
6
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.金属蛋白酶组织抑制剂-4(TIMP-4)在人血小板中的鉴定、调控及作用
Br J Pharmacol. 2002 Dec;137(8):1330-8. doi: 10.1038/sj.bjp.0704936.
7
The mechanisms of coronary restenosis: insights from experimental models.冠状动脉再狭窄的机制:来自实验模型的见解。
Int J Exp Pathol. 2000 Apr;81(2):63-88. doi: 10.1046/j.1365-2613.2000.00143.x.
8
Coronary stent symmetry and vascular injury determine experimental restenosis.冠状动脉支架的对称性和血管损伤决定实验性再狭窄。
Heart. 2000 Apr;83(4):462-7. doi: 10.1136/heart.83.4.462.